Products / Services
  • Products / Services
  • Companies
  • Buy Leads
    Post Buy Requirement
    • UsageClinical, hospital etc.
    • StorageCool and Dry Place
    • StorageCool and Dry Place
    • Dosage5mg
    • Supply TypeManufacturer, Exporter, Supplier, Retailer
    • Preferred Buyer Location All over the world
    View More Details
    Send Enquiry

    Company Information

    location Kandivali East, Mumbai, Maharashtra
    4.3/5fill iconfill iconfill iconfill iconhalf icon(30)
    View Number
    • calendar Member Since 15 Years
    • building Nature of Business Retailer
    • gst icon GST No. 27AAHPM3187H1ZG

    Ask for more detail from the seller

    Contact Supplier
    Report incorrect details
    • Product Details

    • Company Details

    no_img_icon

    • CATEGORYVaccines
    • Packaging TypePlastic Bottle
    • Grade StandardMedicine Grade
    • StorageCool and Dry Place
    • FormTablets / Liquid / Capsules / Powder
    • UsageClinical, hospital etc.
    • StorageCool and Dry Place
    • Dosage5mg
    • ManufacturerSanofi

    MENOMUNE

     

    • multi dose vaccine

     

    Menomune Injection is a multi dose vaccine for prevention against meningitis disease manufactured by Sanofi Pasteur. Its generic name is Meningococcal polysaccharide. It is advised to be taken by Haj pilgrims. The vaccine is an active immunising agent used to prevent infection by certain groups of meningococcal bacteria. The vaccine works by causing your body to produce its own protection (antibodies) against the disease.This information applies only to the meningococcal vaccine used for meningococcal bacteria Groups A, C, Y, and W-135. These groups cause approximately 50% of meningococcal meningitis cases in the U.S. The vaccine will not protect against infection caused by other meningococcal bacteria groups, such as Group B.

    ADDITIONAL INFORMATION

    Meningococcal infection can cause life-threatening illnesses, such as meningococcal meningitis, which affects the brain, and meningococcemia, which affects the blood. Some persons with meningococcal meningitis and/or meningococcemia also may die. These diseases are more likely to occur in young children and in persons with certain diseases or conditions that make them more susceptible to a meningococcal infection or more likely to develop serious problems from a meningococcal infection. Immunisation against meningococcal disease is recommended for persons 2 years of age or older who are at risk of getting the disease because ;

    1. They have certain diseases or conditions that make them more susceptible to a meningococcal infection or more likely to develop serious problems from a meningococcal infection. They are living in, working in, or visiting an area where there is a strong possibility of contracting meningococcal disease.

    2. Usually a person needs to receive meningococcal vaccine only once. However, additional injections may be needed for young children who remain at high risk for meningococcal disease. Meningococcal polysaccharide vaccine is to be administered only by or under the supervision of your doctor or other health care professional.


    Interested in this product? Ask for more details & Latest Price from seller
    Send Enquiry
    Share your requirements for a quick response!
    Tell us what you need?

    Looking for MENOMUNE?

    Quantity
    Seller Contact Details
    To list your productBoost Your Business Visibility WorldwideRegister Now
    To list your productBoost Your Business Visibility WorldwideRegister Now
    Waiting for permission
    To search by voice, go to your browser settings and allow access to microphone

    Allow microphone access to search with voice